The online reseller trading as Adamant Research Supply enters a consent decree and stops sterile preparation
The observation that closes a facility is rarely the dramatic one.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 2 of 6 of this archive, newest first.
The observation that closes a facility is rarely the dramatic one.
Cost is the modal reason for discontinuation in every dataset we have seen, and it is absent from the clinical literature.
The document is four pages. Three of them are about dates.
The observation that closes a facility is rarely the dramatic one.
The observation that closes a facility is rarely the dramatic one.
The observation that closes a facility is rarely the dramatic one.
The document is four pages. Three of them are about dates.
Dose reduction is not withdrawal, and the trials that tested withdrawal cannot be read as testing it.
The document is four pages. Three of them are about dates.
The observation that closes a facility is rarely the dramatic one.
A withdrawal trial answers a narrower question than it appears to. This piece states which question.
Three randomised withdrawal designs have tested what happens when treatment stops. Their results are consistent and they are consistently misreported.
The document is four pages. Three of them are about dates.
The document is four pages. Three of them are about dates.
The observation that closes a facility is rarely the dramatic one.
Cost is the modal reason for discontinuation in every dataset we have seen, and it is absent from the clinical literature.
The document is four pages. Three of them are about dates.
The observation that closes a facility is rarely the dramatic one.
The observation that closes a facility is rarely the dramatic one.
What was withdrawn, from whom, after how long, and what was measured afterwards.